Dynamic regulation of cancer stem cells and clinical challenges
- PMID: 22926945
- DOI: 10.1007/s12094-012-0927-7
Dynamic regulation of cancer stem cells and clinical challenges
Abstract
A small population of cancer cells referred to as cancer stem cells (CSCs) have received particular attention, as they have been revealed to acquire stem cell-like properties and become the main cause of tumor propagation, metastasis and drug resistance. The CSC theory of tumor formation was believed to follow the hierarchical model initially, and therefore many CSC-targeted therapy methods were expected to cure cancer by eradicating CSCs. However, subsequent CSC research has revealed that rather than a distinct entity, the CSC is a dynamic status that can be continually dedifferentiated from progenitor or differentiated cancer cells. Elucidation of this bidirectional transition mechanism would help perfect the CSC theory and be of great value in the development of more effective anti-cancer drugs. Here, we reviewed the mechanisms of reciprocal conversion between non-CSCs and CSCs. Moreover, several approaches of target CSCs and non-CSCs together with unbiased eradication of all cancer cells are also discussed.
Similar articles
-
Basal/HER2 breast carcinomas: integrating molecular taxonomy with cancer stem cell dynamics to predict primary resistance to trastuzumab (Herceptin).Cell Cycle. 2013 Jan 15;12(2):225-45. doi: 10.4161/cc.23274. Epub 2012 Jan 15. Cell Cycle. 2013. PMID: 23255137 Free PMC article.
-
Stem cell programs in cancer initiation, progression, and therapy resistance.Theranostics. 2020 Jul 9;10(19):8721-8743. doi: 10.7150/thno.41648. eCollection 2020. Theranostics. 2020. PMID: 32754274 Free PMC article. Review.
-
The developing cancer stem-cell model: clinical challenges and opportunities.Lancet Oncol. 2012 Feb;13(2):e83-9. doi: 10.1016/S1470-2045(11)70257-1. Lancet Oncol. 2012. PMID: 22300863 Review.
-
Cancer stem cells: distinct entities or dynamically regulated phenotypes?Cancer Res. 2012 Feb 1;72(3):576-80. doi: 10.1158/0008-5472.CAN-11-3070. Cancer Res. 2012. PMID: 22298594 Free PMC article. Review.
-
The clinical and therapeutic implications of cancer stem cell biology.Expert Rev Anticancer Ther. 2011 Jul;11(7):1131-43. doi: 10.1586/era.11.82. Expert Rev Anticancer Ther. 2011. PMID: 21806335 Review.
Cited by
-
Mek inhibition results in marked antitumor activity against metastatic melanoma patient-derived melanospheres and in melanosphere-generated xenografts.J Exp Clin Cancer Res. 2013 Nov 16;32(1):91. doi: 10.1186/1756-9966-32-91. J Exp Clin Cancer Res. 2013. PMID: 24238212 Free PMC article.
-
Exosomes Regulate the Transformation of Cancer Cells in Cancer Stem Cell Homeostasis.Stem Cells Int. 2018 Sep 23;2018:4837370. doi: 10.1155/2018/4837370. eCollection 2018. Stem Cells Int. 2018. PMID: 30344611 Free PMC article. Review.
-
Emerging role of exosome signalling in maintaining cancer stem cell dynamic equilibrium.J Cell Mol Med. 2018 Aug;22(8):3719-3728. doi: 10.1111/jcmm.13676. Epub 2018 May 25. J Cell Mol Med. 2018. PMID: 29799161 Free PMC article. Review.
-
The cancer stem cell niche: cross talk between cancer stem cells and their microenvironment.Tumour Biol. 2014 May;35(5):3945-51. doi: 10.1007/s13277-013-1561-x. Epub 2014 Jan 14. Tumour Biol. 2014. PMID: 24420150 Review.
-
The cancer stem cell niche: how essential is the niche in regulating stemness of tumor cells?Cell Stem Cell. 2015 Mar 5;16(3):225-38. doi: 10.1016/j.stem.2015.02.015. Cell Stem Cell. 2015. PMID: 25748930 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources